Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Biomedical engineering professor Ronald Triolo discusses spinal cord research
- Law’s Sharona Hoffman discusses what to consider when planning for retirement and beyond
- Get all your need-to-know information about fall 2015 tuition, fees
- Support Garden@Case by volunteering this summer, fall
- Plan for the future with new Financial Wellness program